The FDA has approved Rixubis for the treatment of hemophilia B in children, manufacturer Baxter International Inc. announced.
October 2014
Inhibitor screening is important for all hemophilia patients, not just those at high risk, according to a study by the CDC.
Companies will use cell line development studies to determine where factor VIII manufacturing costs can be lowered without sacrificing efficacy.
Advertisement
Advertisement
Trending on HCPLive
1
Navigating Emotional Burden in IBD
2
Highlighting FDA-Approved Therapies in Atopic Dermatitis, With Chris Bunick, MD, PhD
3
Open Communication Between Patients and Providers in IBD
4
Linaclotide in Pediatric IBS-C—Evidence, Indications, and Practical Use
5